SENATE COMMERCE COMMITTEE
STATEMENT TO
SENATE, No. 2886
with committee amendments
STATE OF NEW JERSEY
DATED: FEBRUARY 10, 2025
The Senate Commerce Committee reports favorably and with
committee amendments Senate Bill No. 2886.
This bill requires pharmacies to provide certain information
regarding insulin manufacturer assistance programs.
As amended, under this bill, a pharmacy practice site will be
required to display, in a conspicuous manner, a notice on its
website, concerning insulin manufacturer assistance programs at all
points of sale, the details of which are to be drafted by the
Department of Health. A pharmacy practice site is also required to
provide, upon the request of an individual, a pamphlet created by
the department concerning insulin manufacturer assistance
programs. Insulin manufacturers offering an assistance program
may inform the department of their intention to be included in the
notices and pamphlets. The effective date of the bill is twelve
months from the date it is signed into law.
COMMITTEE AMENDMENTS :
The committee amended the bill to:
(1) require a pharmacy to display, in a conspicuous manner,
information about insulin assistance programs on the website of the
pharmacy and have the Department of Health draft the information to
include on the website;
(2) make the distribution of pamphlets on insulin assistance
programs by request of an individual to the pharmacy; and
(3) alter the effective date to twelve months from the date it is
signed.